Article Information
History
- November 9, 2023.
Article Versions
- Version 1 (November 7, 2023 - 11:43).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Oluwadamilola O. Ojo, MD1,2,
- Sara Bandres-Ciga, PhD3,
- Mary B. Makarious, BSc4,5,
- Peter Wild Crea4,5,
- Dena G. Hernandez, PhD4,
- Henry Houlden, MD6,
- Mie Rizig, MD6,
- Andrew B. Singleton, PhD3,4,
- Alastair J. Noyce, MRCP, PhD7,
- Mike A. Nalls, PhD3,4,8,
- Cornelis Blauwendraat, PhD3,4,
- Njideka U. Okubadejo, MD+ and
- the Nigeria Parkinson’s Disease Research Network and the Global Parkinson’s Genetics Program (GP2)
- 1College of Medicine, University of Lagos, Idi Araba, Lagos State, Nigeria
- 2Lagos University Teaching Hospital, Idi Araba, Lagos State, Nigeria
- 3Center for Alzheimer’s and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
- 4Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA
- 5UCL Movement Disorders Centre, University College London, London, United Kingdom
- 6Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London WC1N 3BG, United Kingdom
- 7Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University London, London, United Kingdom
- 8DataTecnica LLC, Washington, DC, USA
- ↵+Corresponding author:
Prof Njideka U Okubadejo, College of Medicine, University of Lagos and Lagos University Teaching Hospital, Idi Araba, Lagos State, Nigeria, nokubadejo{at}unilag.edu.ng